Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yolanda Blanco

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
Journal of Neurology|December 12, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosisManuel Comabella, Harald Hegen, Luisa M Villar, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Frontiers in Immunology|April 7, 2022
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis PathologyJosé I Fernández-Velasco, Enric Monreal, Jens Kuhle, et al.
Journal of Autoimmunity|December 18, 2020
A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single centerJuan C Sarmiento-Monroy, Gerard Espinosa, Maria-Carlota Londoño, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024)Vilija G Jokubaitis, Raed Alroughani, Ayse Altintas, et al.
Plos Computational Biology|February 8, 2024
Multiscale networks in multiple sclerosisKeith E Kennedy, Nicole Kerlero de Rosbo, Antonio Uccelli, et al.
Neurology|August 27, 2024
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside AttacksElianet Fonseca, Gemma Olivé-Cirera, Eugenia Martinez-Hernandez, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 2025
Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosisYi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective studyJuan Luis Chico-Garcia, Moisés Morales de la Prida, Almudena Boix Lago, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Journal of Neurology|December 12, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosisManuel Comabella, Harald Hegen, Luisa M Villar, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Frontiers in Immunology|April 7, 2022
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis PathologyJosé I Fernández-Velasco, Enric Monreal, Jens Kuhle, et al.
Journal of Autoimmunity|December 18, 2020
A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single centerJuan C Sarmiento-Monroy, Gerard Espinosa, Maria-Carlota Londoño, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024)Vilija G Jokubaitis, Raed Alroughani, Ayse Altintas, et al.
Plos Computational Biology|February 8, 2024
Multiscale networks in multiple sclerosisKeith E Kennedy, Nicole Kerlero de Rosbo, Antonio Uccelli, et al.
Neurology|August 27, 2024
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside AttacksElianet Fonseca, Gemma Olivé-Cirera, Eugenia Martinez-Hernandez, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 2025
Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosisYi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective studyJuan Luis Chico-Garcia, Moisés Morales de la Prida, Almudena Boix Lago, et al.
Pageof 16